High prevalence of autoimmune thyroid diseases in patients with prolactinomas : A cross-sectional retrospective study in a single tertiary referral centre
Elenkova, A; PETROSSIANS, Patrick; Zacharieva, Set al.
PETROSSIANS, Patrick ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
Zacharieva, S
Beckers, Albert ; Université de Liège > Département des sciences cliniques > Endocrinologie
Language :
English
Title :
High prevalence of autoimmune thyroid diseases in patients with prolactinomas : A cross-sectional retrospective study in a single tertiary referral centre
Pellegrini I., Lebrun J.J., Kelly P.A. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992, 6:1023-1031.
Clevenger C.V., Russell D.H., Appasamy P.M., Prystowsky M.B. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 1990, 87:6460-6464.
Yu-Lee L.Y. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med 1997, 215:35-52.
Matera L., Contarini M., Bellone G., Forno B., Biglino A. Upmodulation of interferon-γ mediates the enhancement of spontaneous natural killer cells. Immunology 1999, 98:386-392.
Jones T.H., Price A., Justice S., Chapman K. Interleukin-6 secretion by human pituitary adenomas in vivo. J Endocrinol 1990, 127:86.
Vitetta E.S., Ohara J., Myers C.D. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med 1985, 162:1726-1731.
Jara L.J., Vera-Lastra O., Miranda J.M., Alcala M., Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus 2001, 10:748-756.
Seriolo B., Ferretti V., Sulli A., Fasciolo D., Cutolo M. Serum prolactin concentrations in male patients with rheumatoid arthritis. Ann NY Acad Sci 2002, 966:258-262.
Haga H.J., Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome. J Rheumatol 1999, 26:1291-1295.
Notsu K., Ito Y., Furuya H., Ohguni S., Kato Y. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis. Endocr J 1997, 44:89-94.
Todd G.R., Love A.H., Sheridan B., Kennedy L. Hyperprolactinaemia and coeliac disease. Lancet 1984, 10:574. [1].
Leaños-Miranda A., Cárdenas-Mondragón G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford) 2006, 45:97-101.
Vera-Lastra O., Mendez C., Jara L.J., Cisneros M., Medina G., Ariza R., et al. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol 2003, 30:2140-2146.
Sayki Arslan M., Sahin M., Topaloglu O., Tutal E., Karakose M., Gungunes A., et al. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin Endocrinol (Oxf) 2013, 79:882-886.
Onal E.D., Saglam F., Sacikara M., Ersoy R., Cakir B. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study. Arq Bras Endocrinol Metabol 2014, 58:48-52.
Casanueva F.F., Molitch M.E., Schlechte J.A., Abs R., Bonert V., Bronstein M.D., et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinoma. Clin Endocrinol (Oxf) 2006, 65:265-273.
Melmed S., Casanueva F.F., Hoffman A.R., Kleinberg D.L., Montori V.M., Schlechte J.A., et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:273-288.
Bahn R.S., Burch H.B., Cooper D.S., Garber J.R., Greenlee C., Klein I., et al. Hyperthyroidism and other causes of thyreotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011, 17:456-520.
Petrossians P., Tichomirowa M.A., Stevenaert A., Martin D., Daly A.F., Beckers A. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly. Ann Endocrinol (Paris) 2012, 73:190-201.
R Development Core Team 2011 A language and environment for statistical computing 2011, 625-626. R Foundation for Statistical Computing, Vienna, Austria.
Biondi B., Cooper D.C. The clinical significance oif subclinical thyroid dysfunction. Endocr Rev 2008, 2976-3131.
McLeod D.S., Cooper D.S. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012, 42:252-265.
Szabolcs I., Podoba J., Feldkamp J., Dohan O., Farkas I., Sajgó M., et al. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf) 1997, 47:87-92.
Knudsen N., Jorgensen T., Rasmussen S., Christiansen E., Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol 1999, 51:361-367.
Vejbjerg P., Knudsen N., Perrild H., Laurberg P., Carlé A., Pedersen I.B., et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf) 2009, 71:440-445.
Laurberg P., Nøhr S.B., Pedersen K.M., Hreidarsson A.B., Andersen S., Bülow Pedersen I., et al. Thyroid disorders in mild iodine deficiency. Thyroid 2000, 10:951-963.
Laurberg P., Cerqueira C., Ovesen L., Rasmussen L.B., Perrild H., Andersen S., et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 2010, 24:13-27.
Delange F. Iodine status in Belgium. J Endocrinol Invest 2003, 26:6-7.
Benoist B., McLean, Andersson M., Rogers Iodine deficiency in 2007: global progress since 2003. WHO Food Nutr Bull 2008, 29:195-203.
Kutluturk F., Yildirim B., Ozturk B., Ozyurt H., Bekar U., Sahin S., et al. Thyroid dysfunctions and sonographic characteristics in northern Turkey: a population-based study. Ann Saudi Med 2013, 33:253-259.
Bar-Andziak E., Milewicz A., Jedrzejuk D., Arkowska A., Mieszczanowicz U., Krzyzanowska-Świniarska B. Thyroid dysfunction and thyroid autoimmunity in a large unselected population of elderly subjects in Poland - the "PolSenior" multicentre crossover study. Endocrynol Pol 2012, 63:346-355.
Kovács Z., Gönczi J., Kákosy T., Góth M., Dohán O., Kovács L., et al. Prevalence of thyroid dysfunction in different geriatric subpopulations from a moderately iodine-deficient Hungarian region. Comparative clinical and hormonal screening. Eur J Endocrinol 1995, 133:294-299.
Aghini-Lombardi F., Antonangeli L., Martino E., Vitti P., Maccherini D., Leoli F., et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999, 84:561-566.
Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 2000, 160:526-534.
Hallowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87:489-499.
Konno N., Iizuka N., Kawasaki K., Taguchi H., Miura K., Taguchi S., et al. Screening for thyroid dysfunction in adults residing in Hokkaido Japan: in relation to urinary iodide concentration and thyroid autoantibodies. Hokkaido Igaku Zasshi 1994, 69:614-626.
Teng X., Shan Z., Chen Y., Lai Y., Yu J., Shan L., et al. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol 2011, 164:943-950.
Polyzos N.P., Sakkas E., Vaiarelli A., Poppe K., Camus M., Tournaye H. Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values. Hum Reprod 2015, 30:1690-1696.
Hoogendoorn E.H., Hermus A.R., deVegt F., Ross H.A., Verbeek A.L.M., Kiemeney L.A.L.M., et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006, 52:104-111.
Gussekloo J., van Exel E., de Craen A.J.M., et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004, 292:2591-2599.
Valeix P., Dos Santos C., Castetbon K., Bertrais S., Cousty C., Hercberg S. Statut thyroïdien et fréquences des dysthyroïdies chez les adultes inclus dans l'étude SU.VI.MAX en 1994-1995. Ann Endocrinol (Paris) 2004, 65:477-486.
Delemer B., Aubert J.P., Nys P., Landron F., Bouée S. An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study. Eur J Endocrinol 2012, 167:817-823.
Vanderpump M.P.J. The epidemiology of thyroid diseases. Wegner and Ingbar's. The thyroid: a fundamental and clinical text 2005, 398-406. JB Lippincott-Raven, Philadelphia. 9th ed. L.E. Braverman, R.D. Utiger (Eds.).
Cooper G.S., Bynum M.L.K., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009, 33:197-207.
